Incyte Biosciences Italy S.r.l

1 clinical trials · Sponsor

Record	Firm	Date
Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND) (NCT06299553)	Incyte Biosciences Italy S.r.l	2023-12-04

Every clearance here is in the API, with alerts when new ones post.